Contributing Factors to Medical Malpractice Claims: Study Examines Difference Between No-Payment and Indemnity Claims
In November 2023, The Doctors Company released a study on diagnosis-related medical malpractice claims with an indemnity over $1 million. Now, to expand our understanding, we have conducted a new analysis: Do contributing factors differ between malpractice claims with no payment and claims with indemnity payments?
Search
The Malpractice Experience of Orthopedic Surgeons 2011 to 2021: Patient Selection and Communication May Mitigate Risk of Claims
This study analyzed 1559 closed medical malpractice claims and suits (814 ambulatory, 745 inpatient) from the loss years of 2011 to 2021 in which orthopedic surgeons were the major responsible service.
August 12, 2024, Part B News
Your Patient Wants Records Sent Via Unsecure Email. Are You Covered?
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides recommendations for how to respond when patients request emailed medical records.
Diagnostic Error in General Surgery: Cognitive Bias and Systems Issues in Medical Malpractice Claims (Abstract)
Although claims against general surgeons primarily allege technical surgical-type errors, diagnostic error is the second most frequent allegation against or case type for general surgeons. Analysis of malpractice claims can elucidate the causes of and solutions to diagnostic errors. This study considers differences between diagnostic errors, both cognitive and systemic, committed by general surgeons in the inpatient vs. the outpatient setting.
Jun 17, 2022
RCA2: Panel Report on Improving Root Cause Analyses and Actions to Prevent Harm
James P. Bagian, MD, PE, member of The Doctors Company Board of Governors, co-chaired a panel with the National Patient Safety Foundation to improve how we can learn from adverse events and unsafe conditions and take action to prevent their occurrence in the future.
Apr 30, 2024
Mislabeled Diagnostic Specimens Put Lab Team at Risk: Patient Safety Impact Story
A clinical laboratory team that provides diagnostic evaluation of specimens sent in from multiple practices noticed an increase in tissue specimens arriving mislabeled, prompting a Practice Risk INSIGHT review by The Doctors Company.
Community Investment
We are advocates for the health of the entire community—in and out of the clinical setting.
The Tribute Plan Frequently Asked Questions
The Tribute Plan is a breakthrough financial benefit that rewards eligible members for their loyalty to The Doctors Company and for their commitment to superior patient care.
Obtaining Informed Consent in Clinical Teaching Situations
The basic principles governing informed consent and informed refusal apply to healthcare practitioners in all settings—including academic medical centers and any teaching location.
April 03, 2025, Cardiology Magazine
Critical Insights: Lessons From Delayed Diagnosis, Treatment in the ED
John P. Erwin III, MD, MBA, MACC, Chair, Department of Internal Medicine, Prisma Health Upstate; Clinical Professor, School of Medicine Greenville, University of South Carolina; and Debra A. Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager, The Doctors Company, part of TDC Group, review how care and treatment delays contribute to poor patient outcomes and medical malpractice litigation.
